K-ras mutations and cell kinetics in Helicobacter pylori associated gastric intestinal metaplasia: a comparison before and after eradication in patients with chronic gastritis and gastric cancer
- J Watari1,
- A Tanaka1,
- H Tanabe1,
- R Sato1,
- K Moriichi1,
- A Zaky1,
- K Okamoto1,
- A Maemoto1,
- M Fujiya1,
- T Ashida1,
- K M Das2,
- Y Kohgo1
- 1Division of Gastroenterology and Hepatology, Department of Medicine, Asahikawa Medical College, Asahikawa, Japan
- 2Crohn’s and Colitis Center of New Jersey, Division of Gastroenterology and Hepatology, Department of Medicine and Pathology, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ, USA
- Correspondence to: Dr J Watari Division of Gastroenterology and Hepatology, Department of Medicine, Asahikawa Medical College, 2-1-1-1 Midorigaoka-Higashi, Asahikawa 078-8510, Japan; jiro{at}asahikawa-med.ac.jp
- Accepted 14 August 2006
Abstract
Background:Helicobacter pylori related gastric intestinal metaplasia (IM) is considered to be a precancerous lesion.
Aims: To identify the effects of H pylori eradication on K-ras mutations, cell kinetics in IM and histological changes in patients with and without gastric cancers in a one-year prospective study.
Methods: Patients included group A (n = 39), chronic gastritis, and group B (n = 53), intestinal-type early gastric cancer patients who had all undergone endoscopic mucosal resection (n = 25) or surgical resection (n = 28). K-ras codon 12 mutations in IM were examined, followed by DNA sequencing analysis. Proliferating and apoptotic cells were detected with anti-Ki-67 antibody and using the TUNEL method, respectively.
Results: The incidence of K-ras mutations in the cancer was only 3.8%. The mutant K-ras in IM was observed more frequently in group A (46.2%) than in group B patients (1.9%) (p<0.005). After eradication, the K-ras mutations significantly declined to 12.8% in group A (p<0.005). The mutation pattern of K-ras codon 12 before eradication was that GGT was mainly changed to AGT (50%) in group A. AGT transformation was not affected by treatment. Apoptosis in IM showed an increase after H pylori eradication in both groups (p<0.05 in group A) although no histological improvement in IM was observed. The monocyte score was significantly higher in group A than in group B (p<0.05); the score improved significantly after eradication.
Conclusions: K-ras mutations in IM do not always play a role in gastric carcinogenesis but cell kinetics, especially apoptosis, in IM may contribute to it. There are early events in K-ras mutations which are influenced by H pylori infection; some mutations may also be selected by eradication. These unstable K-ras mutations in IM may be related to lymphocyte infiltration caused by H pylori infection.
- AI, apoptotic index
- EMR, endoscopic mucosal resection
- IM, intestinal metaplasia
- PI, proliferative index
Footnotes
-
Published Online First 22 September 2006
-
Competing interests: None declared.








